Chemo may be given on its own or as one piece of a combined treatment plan alongside other modalities such as surgery, radiation therapy, immunotherapy, or targeted therapy. For many types of abdominal cancers, a multimodal approach – combining two or more treatments – offers the best chance of long-term control. Your oncology team will tailor the combination and sequence based on tumor type, stage, and your overall health. [3,4]

How is Chemotherapy Used with a Surgical Treatment Plan?

Chemo is delivered in cycles – typically a treatment day (or several days) followed by 1–3 weeks of rest to let your body recover. A full course usually runs 3 to 6 months total, though it can be shorter or longer depending on the cancer and how you tolerate treatment. [5-7]

Neoadjuvant

• WHEN: Before Surgery

• PURPOSE: Shrink the tumor and address microscopic spread early

• TYPICAL LENGTH: A few weeks up to a few months (commonly 2-4 months); surgery usually follows within ~4 weeks of finishing

Adjuvant

• WHEN: After Surgery

• PURPOSE: Eliminate any cancer cells left behind to lower recurrence risk

• TYPICAL LENGTH: Usually 3-6 months, started within ~6-8 weeks after surgery once you've healed

In many abdominal cancers, you may receive both – known as perioperative chemotherapy – for a combined total of roughly 6 months of treatment, split before and after surgery.

Chemotherapy as a Standalone or Palliative Treatment

Not every patient has surgery as part of their plan. When cancer has spread, when surgery isn't safe, or when the tumor can't be fully removed, chemo may be used as the primary treatment to control the disease for as long as possible. In this setting it is often called palliative chemotherapy – the aim isn't to cure, but to shrink tumors, slow their growth, ease symptoms (such as pain, nausea, or blockage from a tumor pressing on the bowel or bile duct), and improve quality of life. Treatment may continue as long as it's working and well-tolerated, with regular scans every few months to reassess; if one regimen stops working, your care team may switch to a different combination. [8]

When is Chemotherapy Used for Peritoneal Metastases?

When cancer cells spread to the lining of the abdomen – called the peritoneum – current guidelines still recommend systemic chemotherapy at some point in the majority of patients. These guidelines often call for using the same regimens given for other forms of metastatic cancer (typically platinum- and fluoropyrimidine-based combinations, sometimes with targeted agents or immunotherapy agents).

One important limitation to be aware of: because the peritoneum has a relatively poor blood supply, IV (intravenous) and oral chemotherapy drugs don't penetrate it as effectively as they reach other sites throughout the body - in other words, chemotherapy many not reach those tumors effectively, which means it can be less effective at killing the cancer cells. This can make peritoneal disease harder to control with systemic chemo alone. For carefully selected patients, your team may discuss adding local approaches – such as cytoreductive surgery with HIPEC or PIPAC — alongside systemic treatment; these are considered in specialized centers and depend on the type of cancer, extent of peritoneal spread, and your overall condition. [11]

When considering a plan of care that may include systemic chemotherapy for an abdominal cancer diagnosis, talk with your doctor about the recommended treatment and its effectiveness in reaching the cancer and treating your diagnosis.